The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Medworxx Celebrates Royal Liverpool and Broadgreen University Hospitals NHS Trust Being Recognized as a Healthcare Quality Leader

<p class='bwalignl'> <i>On the heels of the Mersey Region Quality Award, momentum continues to build as Royal Liverpool and Broadgreen University Hospitals NHS Trust locks its place as one of the top finalists for the prestigious EHI Awards</i><br/><br/><a href='http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ehealthawards.com%2Foutstanding-work-in-it-enabled-change-in-healthcare&esheet=50418825&lan=en-US&anchor=EHI+LIVE+2012&index=1&md5=8a05a1a78bcf0aab9b574dd125e63727'>EHI LIVE 2012</a> </p> <p> </p>

Tuesday, September 25, 2012

Medworxx Celebrates Royal Liverpool and Broadgreen University Hospitals NHS Trust Being Recognized as a Healthcare Quality Leader05:00 EDT Tuesday, September 25, 2012 TORONTO (Business Wire) -- Medworxx Inc. (“Medworxx”) (TSXV: MWX), a leader in clinical patient flow, compliance and education solutions, is pleased to announce client Royal Liverpool and Broadgreen University Hospitals NHS Trust's success and recognition for engaging a case management system with measurable results in improving patient flow and patient care. The Trust has been recently nominated as one of the top finalists for the national EHI Awards' category of ‘Outstanding work in IT-enabled change in healthcare' for the project titled, ‘First UK IT-enabled case management system'. The solution optimizes patient flow by alerting case managers of necessary factors for the planning of safe and effective patient discharges. The Trust reported a 30% reduction in delayed transfers of care in three months of the solution's implementation. “This new system, together with the introduction of new hospital case managers into departments, is helping to ensure that patients don't have to stay in hospital any longer than they need to and are appropriately supported when they are discharged,” says Trish Armstrong-Child, Director of Operations at the Royal Liverpool and Broadgreen University Hospitals NHS Trust. Armstrong-Child will be speaking within the EHI Awards stage on the first day of the two-day exhibition and conference, EHI LIVE 2012 that will take place at the NEC, Birmingham 6th to 7th of November, 2012. “Our investment in the Medworxx Utilization Management solution, is the first of its kind in the UK and Europe. It has helped us to improve the patients' journey and experience of care throughout the hospital, enabling us to manage their care more efficiently and avoid delays in their discharge,” she adds. “We are delighted to be shortlisted for this prestigious award in recognition of our investment into managing patient care more efficiently.” The Trust was also recently ranked first for quality improvement in the Mersey Quality Awards by commissioners of local health services; NHS Merseyside. This award recognizes the achievements the Trust has made in improving patient care and reducing length of stay since the introduction of the new case management system. “This award was hugely significant in illustrating our ongoing commitment to service re-design, quality improvement, value for money and improved patient care that the Medworxx Utilization Management solution has helped us to achieve,” says Armstrong-Child. Medworxx Patient Flow, including Medworxx Utilization Management and Medworxx Bed Board, provides hospitals with tools to bridge clinical and operational perspectives on daily patient flow – optimal for healthcare systems addressing issues of overcapacity, wait times and care coordination. Spurred onwards by uptake of the patient flow solution in 21,000 acute care beds in Canada and United Kingdom's National Health System (NHS), and a recent launch into the United States, Medworxx is expanding to leverage growth that includes agreements with four of Canada's 10 Provinces and also includes 1,000 beds in the UK NHS Trust. About the Royal Liverpool and Broadgreen University Hospitals NHS Trust The Royal Liverpool and Broadgreen University Hospitals NHS Trust is one of the largest and busiest hospital trusts in the North of England, with an annual budget exceeding £400 million. It delivers services across two sites and three hospitals, the Royal Liverpool University Hospital, Broadgreen Hospital and Liverpool University Dental Hospital and employs more than 5,500 people. Each year the Trust sees more than half a million people in its outpatient department and deals with around 150,000 emergency patients and day case admissions. It is one of the top teaching trusts in the UK with well-established links to the University of Liverpool, Liverpool John Moores University and international institutions too. In 2013 work will begin on a new £450 million state of the art Royal Liverpool University Hospital. Online: www.rlbuht.nhs.uk About Medworxx Medworxx delivers health information technology solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Utilisation Management—flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components—currently serves over 30% of the acute care beds in Canada. Synergies in the Canadian and UK health systems led ModelAdvice DC Consulting and Medworxx to collaborate in addressing the UK market, with a focus on NHS Trust hospitals. Model Advice DC methodology for approaching vertical health system integration combines with Medworxx Patient Flow tools to harvest data and intelligence, to model hospitals' patient flow needs and future requirements. Founded in 2004, Medworxx Inc. is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX Online: http://www.medworxx.com LinkedIn: linkedin.com/company/medworxx Twitter: @Medworxx The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release. DisclaimerThe statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company's expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.Medworxx Inc.Alineh HaideryPublic Relations SpecialistMedworxx700 ? 121 Richmond St West, Toronto, Canada M5H 2K1T: 1.800.321.1591 | T: 416.642.1278 x332ahaidery@medworxx.com| www.medworxx.comorDan MatlowPresident & Chief Executive Officer Medworxx700 ? 121 Richmond St West, Toronto, Canada M5H 2K1T: 1.800.321.1591 | T: 416.642.1278 x311dmatlow@medworxx.com| www.medworxx.com